University of Arkansas for Medical Sciences
UAMS BioVentures exists to convert Arkansas medical and biotechnology research into new agreements and new companies focused on improving human healthcare, while providing economic development for Arkansas.
Innovations (33):
- The NU Bite Block – a mouth guard medical device (10-02) (11 FEB 10)
- New tocopherol and tocotrienol analogues with enhanced transport properties and uses in therapy and nutrition (10-01) (11 FEB 10)
- Topical Alpha-Melanocyte Stimulating Hormone: a powerful Anti-Inflammatory pharmaceutical composition for use in established Allergic Contact Dermatitis (09-28) (11 FEB 10)
- A Method of human Therapy Using Wildtype Adeno-Associated Viral (AAV) Vectors (96-11) (01 DEC 09)
- Secreting Products from Skin by Adeno-Associated Virus (AAV) Gene Transfer (99-29) (01 DEC 09)
- Method of Producing Infectious Papillomavirus in Placental Cells (00-20) (01 DEC 09)
- Development of a Chlamydia Specific Vaccine Strain (06-11) (25 NOV 09)
- Composition, Methods and Products Comprising Human Papillomavirus for Detecting and Treating a Cancer (00-25) (19 OCT 09)
- Specific inhibitors of Human UDP-Glucuronosyltransferases Enhance the Efficacy of Selected Antivirals by Changing their Pharmacokinetic Profiles (09-24) (25 SEP 09)
- Predictive Medicine: Risk-adapted Therapy in Multiple Myeloma with combined abnormal Chromosomes 1 and 13 Confers Resistance to Thalidomide in Total Therapy 2 and is linked to Hyper-expression of the IL6R Gene in Malignant Plasma Cells (09-29) (23 SEP 09)
Find more innovations
